Vaccine Manufacturing Technology and Services: World Market 2011-2021

Vaccine Manufacturing Technology and Services: World Market 2011-2021


October 6, 2011
115 Pages - SKU: VSG6690794
License type:
Electronic Access - Single User Fulfilled By Publisher      US $2,323.00
Electronic Access - Departmental 1-5 Users      US $4,648.00
Electronic Access - Global Site License Fulfilled By Publisher      US $10,848.00
Vaccine Manufacturing Technology and Services: World Market 2011-2021

  enlarge


What does the future hold for the vaccine manufacturing industry and market? Visiongain's report shows you potential revenues and trends to 2021. Find opportunities and prospects.

Do you want to know where the market is heading? Discover activities shaping the vaccines market and the outsourcing of vaccine manufacturing for human healthcare. Through our research and analysis we aim to save you time and help in your decisions.

Vaccine manufacturing will become more important this decade. Our study discusses activities of GSK, Sanofi, Merck & Co., Novartis, Pfizer and others. See how changes in the pharma industry affect production, outsourcing and contract service providers (CMOs).

There, you find potential revenues for vaccines at total world and submarket levels to 2021. You also find revenue predictions for contract vaccine manufacturing. You receive forecasts of vaccine volumes (by dose) too, including geographical production data.

What are the prospects for the outsourcing market? Assess SynCo Bio Partners, Baxter BioPharma Solutions and Meridian Life Sciences. Find information you need. Markets and R&D for vaccines remain strong, with opportunities for vaccine manufacturing specialists.

We discuss egg-based systems, mammalian cell lines, avian cell lines, plant-based systems, expression systems, vectors, adjuvants, delivery systems and formulations. You see the potential for technologies and services for vaccine production from 2011 onwards.

Our report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. You can find answers now in our work.

Forecasts, market shares, commercial trends, discussions and interviews

In our report you find forecasts of revenues and volumes, as well as market shares. You also receive qualitative analyses, opinions from industry and a review of companies. Discover 42 tables and charts and two research interviews.

Advantages of Vaccine Manufacturing Technology and Services: World Market 2011-2021 for your work

Our report gives you the following advantages in particular:
  • Discover revenue forecasts to 2021 for the world vaccines market and its main submarkets, finding growth potential
  • See revenue forecasting to 2021 for the outsourced production of vaccines
  • Receive forecasts of production volumes (by dose) to 2021 for the world, North America, France, Germany, Belgium, Switzerland and Austria
  • Find trends in vaccine production technologies and services
  • Review leading companies in vaccine manufacturing, finding activities and outlooks
  • Assess competition and opportunities that will influence revenues
  • See what will stimulate and restrain the industry and market from 2011
  • View opinions from our survey, reading interviews.
There, you find a distinctive mix of quantitative and qualitative analysis with independent predictions. We tackle crucial questions on vaccine production, helping you to stay ahead.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


Additional Information


Report Excerpt

4.1.1 Vaccine Types

This report categorises the global vaccines market into its various classes, as shown in Table 4.1. Hepatitis, influenza and cancer prophylaxis continue to be the three largest single therapeutic areas for vaccines. Vaccines aimed exclusively at children, largely a complex range of combination vaccines, are grouped as paediatric vaccines. Currently, therapeutic vaccines constitute only a small sector of the global vaccines market. For the purposes of this report, all remaining vaccines are grouped in the class adult/other vaccines, as vaccines in this class are mainly targeted at adults.

Companies Listed

AAI Pharma Services Corp.
A-Bio Pharma Pte
Acambis
ADImmune
Advanced Bioscience Laboratories
AfriVax
Alpha Biologics
Althea Technologies
Angel Biotechnology Holdings
ANVISA
Artelis
Astellas
AstraZeneca
ATMI LifeSciences
Bavarian Nordic
Baxter BioPharma Solutions
Baxter International
Beijing Hau-er-dun Biotech Co.
Beijing Tiantan Biological Products Co.
Bharat Biotech International
Bill and Melinda Gates Foundation
Biogen
Biogen Idec
Bio Farma
Biological E
Bio-Manguinhos
Biomay
Biomed Pvt.
Biomedical Advanced Research and Development Authority (BARDA)
BioNet-Asia Co.
BioProperties Pty.
Biovian
Birmex
Cantacuzino Institute
Catalent Pharma Solutions
Cellexus
Central Research Institute
Charles River Biopharmaceutical Services
Changchun BCHT Pharmaceutical Co.
Changchun Institute of Biological Products
Chengdu Institute of Biological Products
China National Biotec Group
Chiron
Chongqing Jianchen Bioengineering Co.
Chongqing Kangwei Biological Co.
Cognate Bioservices
Cytovance Biologics
Crucell
CSL
Daiichi-Sankyo
Dalian Hissen Bio-pharm Inc.
Dalian Jingang Andi Bio-products Co.
Dalian Jingang Biological Products Co.
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (US HHS)
Diosynth Biotechnology
DSM Biologics
Eden Biodesign
Eurogentic Biologics
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency (EMA)
European Vaccine Manufacturers (EVM)
Finlay Institute
Florida Biologix
Formatech
GAVI Alliance
GE Healthcare
GlaxoSmithKline (GSK)
GlaxoSmithKline Biologicals
Goodwin Biotechnology
Government Pharmaceutical Organisation
Green Cross
Haiwang Interlong
Halfkine Bio-Pharmac
Health Canada
Henan Puxin Bio-engineering Co.
HollisterStier
Hospira
Hualan Biological Engineering
Human Biologicals Institute
IDT Biologika
Indian Immunologicals
Innogenetics Biologicals
Instituto Fundaco Butantan
Intercell
International Federation of Pharmaceutical Manufacturers and Association (IFPMA)
Jiangsu Yanshen Biological Technology Co.
Korean FDA
Kuhner
Kunming Institute of Medical Biology
Lanzhou Institute of Biological Products
LG Life Sciences
Livzon Pharmaceutical Biotech Co.
Medicago
MedImmune
Merck & Co.
Meridian Life Science
Millipore
Mitsubishi Tanabe
Mogam Biotechnology Research Institute
Nanjing Dalu Dekang Biotech Co.
National Health Service (UK NHS)
National Institute of Allergy and Infectious Diseases
National Institutes of Health (US NIH)
National Institute of Vaccines and Biological Substances
National Vaccine & Serum Institute (NVSI)
NCPC GeneTech Biotech Dev. Co.
Novartis
Novartis Vaccines and Diagnostics Division
Novavax
Pall Life Sciences
Panacea Biotech Limited
Pan American Health Organization (PAHO)
Pfenex
Pfizer
Pfizer Vaccines
PharmAthene
Phillip Morris International
Pierre-Guerin Biolafitte
Protein Sciences Corporation (PSC)
Queen Saovabha Memorial Institute
Razi Vaccine and Serum Research Institute
Research Triangle Park
Sanofi
Sanofi Pasteur
Sartorius Stedium
Serum Institute of India
Shanghai Fudan-Yueda Biotech Co.
Shanghai Institute of Biological Products
Shanghai Institutes for Biological Sciences
Shantha Biotechnics
Shanxi Institute of Biological Products
Shenyang Baiao Biotech Co.
Shenzhen Neptunus Interlong Biotech Co.
Sinovac Biotech
Solvay
SynCo Bio Partners
Takeda
The Biovac Institute
Thermo Scientific
UNICEF
US Federal Government
Vabiotech
Vivalis
Wockhardt
Wuhan Institute of Biological Products
World Health Organization (WHO)
Wyeth (now part of Pfizer)
Wyeth Vaccines
Xcellerex
Xiamen Innovax Biotech Co.
Yunnan Wosen Biotechnology Co.
Zhejiang Pukang Biotechnology Co.
Zhejiang Tianyuan Bio-pharma Co.
Zhejiang Tianyuan Bio-Pharmaceutical Co.
Zydus Cadila

More Vaccines reports by Visiongain

World Vaccines Market 2013-2023 by Visiongain
World Vaccines Market 2013-2023 Vaccines and their technology - your guide to developments, opportunities, and revenues See what the future holds for vaccines. ...
Hepatitis Drugs and Vaccines: World Market 2013-2023 by Visiongain
Hepatitis Drugs and Vaccines: World Market 2013-2023 Where are hepatitis medicines going? Visiongain's updated report predicts revenues there from 2013 to 2023. It also ...
Vaccine Manufacturing Technology and Services: World Market 2013-2023 by Visiongain
What's the outlook for producing vaccines? Visiongain's updated report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for those technologies. ...
World Vaccines Market 2012-2022 by Visiongain
Why the vaccine market can expand - you discover its commercial potential Where is the vaccines sector heading? Visiongain's report shows you forecasted ...
See all reports like this >>

 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!